STAR Group CEO Josef Zibung shares his position on the
recent industry take-overs and how STAR prefers to stay single.
The translation and localization
market has been through some turbulent times in recent years; with new
companies appearing on the scene; others forced to close, and a
multitude of mergers and acquisitions. One of the key factors driving
this is competition for technological innovation to maintain
translation services. Two major recent events lend weight to this
observation: firstly the SDL takeover of TRADOS and secondly the
Lionbridge takeover of the Translation Technology department of Bowne
Global Solutions. The fact that other companies are now switching over
to the strategy successfully followed by STAR for 20 years - the
combination of tools and services for the entire information process -
is neither surprising nor alarming. In the wake of such events, there
is no lack of speculation about the future of those companies not
involved in these transactions. Reason enough, therefore, for STAR to
make its position clear, to answer some questions and to pull the
carpet from under false rumours.
SDL / Trados
The takeover of TRADOS by SDL was announced on 8 July 2005. This move
comes as no surprise. However, some of the figures being thrown around
about this deal need to be put into perspective. Namely, some
specialist publications have commented on this takeover in the light of
the results of a poll conducted among LISA members (LISA=Localization
Industry Standards Association) which suggests that 71% of those polled
use Trados Workbench while 28% work with SDLX, i.e. a total of 99% of
users. This creates the impression that all the other vendors -
including STAR - are left to fight over a meagre 1% share of the
market. This adding together of the
ostensible market shares of individual vendors gives an entirely
inaccurate picture for a number of reasons. Many subcontractors
(translators) use a number of systems depending on the customer. If one
were to exaggerate and assume that every translator uses three systems,
then each vendor would have a market share of 100%. The truth of the
matter will lie between these two extremes. However, this once again
highlights the fact that such statements are largely worthless and are
misused for marketing purposes.
The assurance that both product lines - Trados and SDLX - will be
continued and also will definitely be supported in future is intended
to allay fears among users. In the long term, however, it is likely
that one of the products will fall by the wayside, which will be
painful for one of the existing groups of customers: will it hit the
28%, the 71% or perhaps even everyone?
What is STAR doing?
STAR will not exploit this situation by now bringing out cut-price
versions of its own high-grade tools - this would not only diminish the
financial investments of existing customers, but perhaps also shake
their long-standing confidence in the STAR strategy. Rather, STAR
offers all technical translators and companies the cost-neutral option,
using existing conversion tools, of migrating their current translation
memories or terminology to the time and tested, reliable Transit
product line. This guarantees the reuse of existing data without
additional investment while at the same time allowing the use of proven
STAR concepts and technologies.
Lionbridge / Bowne Global Solutions
According to an announcement made at the end of June 2005, Lionbridge
is taking over the Translation Technology department of Bowne Global
Solutions. This acquisition means that the second-biggest player in the
market is gobbling up the previous market leader. Both vendors are
active predominantly in the offshore localization market, which,
although having the greatest growth potential, is also the most
fiercely contested market and extremely price-critical. Lionbridge is
today investing significant capital in this acquisition and will in
future be forced to plough in yet further resources in order to carry
through the process of integration, a process which is known to be
difficult in such cases. It will be revealing how the stock market
reacts to this move and what results come out of it in the long term.
What is STAR doing?
STAR is not making any acquisitions, is not being taken over and is not a candidate for mergers.
There will be no change in the existing strategy: STAR will remain
faithful to its proven concept of offering the latest developments as
well as a task- and technology-oriented mode of working and will in
future invest even more in the basic foundations of the technological
information world. In this way, STAR, through its own efforts and
without buying other firms, has evolved into a company with 775
permanent members of staff at 35 globally networked branches. The
successful combination of experienced specialists and a
tried-and-tested strategy will continue in the future to represent the
only sure way of winning long-term market share and sales without
neglecting customer needs.
STAR will remain faithful to its policy of stability and healthy
growth. The consolidated annual financial statements of the STAR Group
for the 2004 fiscal year confirm the correctness of this approach:
following stable growth in recent years, there was a double-digit
percentage improvement in performance in 2004. We expect to exceed this
growth in the current 2005 fiscal year.
STAR can afford to look upon this shake-up in the translation industry
not only with a shrug of its shoulders, but even with a twinkle in its
eye: For is it not a merger of competitors which once again
results in STAR - the biggest unlisted company in this sector - moving
up yet another rung on the global ladder?
Josef Zibung CEO, President STAR Group
About STAR: Headquartered in
Ramsen Switzerland, STAR Group is one of the world's largest providers
or multilingual services and technology. The company employs over 775
people in its 35 global offices. For more information on contact or
corporate headquarters in STAR AG Switzerland: info@star-group.net
For further press information, please contact:
STAR AG, Switzerland, Jasmin Heinemann: +41 52 742 92 00 or email: Jasmin.heinemann@star-group.net
Imperial’s entire focus is on providing clinical trial study material solutions to the pharmaceutical, biotech and device industry. Many of our projects are global in nature and involve some level of translation services.